MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Caution on new anti-obesity drug in kids

Back to weightwatch Blogs list Cancer blog  


Subscribe To Weightwatch RSS Feed  RSS content feed What is RSS feed?

Caution on new anti-obesity drug in kids




Anti-obesity drugs that work by blocking brain molecules similar to those in marijuana could also interfere with neural development in young children, as per a new study from MITs Picower Institute for Learning and Memory.

Marijuana is known to be an appetite stimulant, and a new class of anti-obesity drugssuch as rimonabant (trade name Acomplia) developed by Sanofi-Aventis and awaiting approval for use in the United Stateswork by blocking brain receptors that bind to marijuana and other cannabinoids.

Marijuana, derived from the plant Cannabis sativa, contains special active compounds that are referred to collectively as cannabinoids. But other cannabinoids (endocannabinoids) are generated naturally inside the body.



Caution on new anti-obesity drug in kids

The MIT study, which was done in mice, observed that blocking cannabinoid receptors could also suppress the adaptive rewiring of the brain necessary for neural development in children. The work is published in the May 8 issue of Neuron.

Our finding of a profound disruption of cortical plasticity in juvenile mice suggests caution is advised in the use of such compounds in children, wrote lead author Mark F. Bear, director of the Picower Institute and Picower Professor of Neuroscience.

The scientists investigated plasticitythe brains ability to change in response to experienceby temporarily depriving newborn mice of vision in one eye soon after birth. This well-known experiment induces a long-lasting loss of synapses that causes blindness in the covered eye, while synapses shift to the uncovered eye. How and where this synaptic shift occurs in the primary visual cortex has remained controversial.

Understanding the mechanism behind this phenomenon is key because the same brain mechanisms are used for normal development and may go awry in conditions that cause developmental delays in humans, and may reappear in old age and contribute to synaptic loss during Alzheimer's disease, Bear said.

In mice, the MIT scientists found, even one day of deprivation from one eye starts the shift to dominance of the uncovered eye. But injecting the mice with a cannabinoid receptor blocker halted the shift in certain brain regions, indicating that cannabinoids play a key role in early synaptic development.

Blocking cannabinoids receptors could thwart this developmental process, the scientists said.


Posted by: JoAnn    Source




Did you know?
Anti-obesity drugs that work by blocking brain molecules similar to those in marijuana could also interfere with neural development in young children, as per a new study from MITs Picower Institute for Learning and Memory. Marijuana is known to be an appetite stimulant, and a new class of anti-obesity drugssuch as rimonabant (trade name Acomplia) developed by Sanofi-Aventis and awaiting approval for use in the United Stateswork by blocking brain receptors that bind to marijuana and other cannabinoids.

Medicineworld.org: Caution on new anti-obesity drug in kids

Asthma| Hypertension| Medicine Main| Diab french| Diabetes drug info| DruginfoFrench| Type2 diabetes| Create a dust free bedroom| Allergy statistics| Cancer terms| History of cancer| Imaging techniques| Cancer Main| Bladder cancer news| Cervix cancer news| Colon cancer news| Esophageal cancer news| Gastric cancer news| Health news| Lung cancer news| Breast cancer news| Ovarian cancer news| Cancer news|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.